Develops cell therapies for autoimmune diseases and cancer.
Dec 2025Revenue $109M/yrExpenses $126M/yr
No trendCash runway ≈ 1.4 years from Jun 2026
Figures by year
When will Century Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $109M and expenses $126M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $109M | $126M | −$17.3M |
| Dec 2024 | $6.59M | $145M | −$138M |
| Dec 2023 | $2.23M | $149M | −$147M |
| Dec 2022 | $5.20M | $139M | −$134M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.